Latest News and Press Releases
Want to stay updated on the latest news?
-
BASEL, Switzerland, Nov. 19, 2003 (PRIMEZONE) -- Novartis will today present its pharmaceutical pipeline to the media and financial community at our annual 'R&D Day' event in New York. Please...
-
BASEL, Switzerland, Nov. 17, 2003 (PRIMEZONE) -- To the Editors Novartis' 2003 "R&D day" Basel, 17 November 2003 On Wednesday, 19 November 2003 Novartis will present its pharmaceutical...
-
BASEL, Switzerland, Oct. 30, 2003 (PRIMEZONE) -- Health authorities in the UK and Australia (the National Institute for Clinical Excellence (NICE) and the Minister of Health and Ageing,...
-
BASEL, Switzerland, Oct. 20, 2003 (PRIMEZONE) -- Novartis (NYSE:NVS): -- Group nine-month sales up 18%; Pharmaceuticals climbs 18% and continues to outpace the market; Sandoz posts 67% sales...
-
BASEL, Switzerland, Oct. 16, 2003 (PRIMEZONE) -- Novartis (NYSE:NVS) Nine-month and third-quarter results 2003 now available Online. Please see full press release under the following link:...
-
BASEL, Switzerland, Oct. 08, 2003 (PRIMEZONE) -- Novartis (NYSE:NVS) has signed an agreement with Sankyo (TSE: 4501) of Japan to co-develop and subsequently commercialize a treatment for...
-
BASEL, Switzerland, August 19, 2003 (PRIMEZONE) -- Novartis (NYSE:NVS) announced today that its generics unit Sandoz is launching a generic form of the anti-ulcer treatment Prilosec(r) (omeprazole)...
-
BASEL, Switzerland, July 21, 2003 (PRIMEZONE) -- Novartis (NYSE:NVS) delivers strong first-half performance and continues to gain market share. - Group sales up 20%; Pharmaceuticals climbs 18%,...
-
BASEL, Switzerland, July 17, 2003 (PRIMEZONE) -- Please note that Novartis International AG (NYSE:NVS) will publish its Group financial results for the first-half and second-quarter of 2003 on Monday...
-
BASEL, Switzerland, July 10, 2003 (PRIMEZONE) -- Novartis (NYSE:NVS) announced that its affiliate companies have reached an agreement with GlaxoSmithKline (NYSE:GSK) over lawsuits related to GSK's...